The latest research study “Cancer Cachexia Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global cancer cachexia market reached a value of US$ 1.88 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 2.53 Billion by 2027, exhibiting a CAGR of 4.80% during 2022-2027.
Cancer cachexia is a multifactorial, host-phagocytic wasting syndrome that leads to systemic inflammation, involuntary loss of lean body mass, poor protein and energy balance, loss of appetite, and muscular atrophy. It is caused by the occurrence of chronic illnesses, such as human immunodeficiency virus (HIV), multiple sclerosis, chronic obstructive pulmonary disease (COPD), and tuberculosis (TB). It can be treated with numerous therapeutics, including progestogen, corticosteroid, and combination therapy. A progestogen is a type of steroid hormone that increases appetite and encourages weight gain, whereas corticosteroid helps reduce inflammation and suppress the overactive immune systems. As a result, cancer cachexia treatment is gaining immense traction across the globe.
Download a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/cancer-cachexia-market/requestsample
Cancer Cachexia Market Trends and Drivers:
The global cancer cachexia market is primarily driven by the rising prevalence of cancer and cachexia, especially among the geriatric population. Moreover, the shifting patient preferences toward combinational therapies for improving lean body mass (LBM) through pharmacological and non-pharmacological treatments and clinical trials are positively influencing the market growth.
Additionally, the increasing use of numerous appetite stimulants, including megestrol acetate, dexamethasone, and methylprednisolone, to enhance digestion is another major growth-inducing factor. Besides this, the rising consumer awareness about the availability of novel therapeutic medicines to treat cancer cachexia has catalyzed market growth.
Furthermore, numerous technological advancements that focus on the development of effective cancer cachexia medicines are contributing to market growth. Other factors, including ongoing research and development (R&D) activities, favorable government policies, and the aging population, are also anticipated to drive the market further.
Global Cancer Cachexia Market 2022-2027 Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Cancer Cachexia Companies:
AAVogen Inc., Actimed Therapeutics Ltd., Aphios Corporation, Artelo Biosciences Inc., AVEO Pharmaceuticals Inc., Fresenius Kabi AG (Fresenius SE & Co. KGaA), Helsinn Healthcare SA, Merck & Co. Inc., NGM Biopharmaceuticals Inc., Pfizer Inc. and Tetra Bio-Pharma.
The report has segmented the market on the basis of region, therapeutics, mode of action and distribution channel.
Breakup by Therapeutics:
- Progestogens
- Corticosteroids
- Combination Therapy
- Others
Breakup by Mode of Action:
- Appetite Stimulators
- Weight Loss Stabilizers
Breakup by Distribution Channel:
- Hospital Stores
- Retail Pharmacy
- Online Pharmacy
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=5338&flag=C
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
